MYOTHERIX, INC. — Form D
MYOTHERIX, INC. of Emeryville, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-01. The offering totals $7.9M, of which $7.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-01
- Form: D
- Accession: 0001647149-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.9M
- Amount sold: $7.9M
- Investors: 15
- Date of first sale: 2017-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281503
Issuer
- Name: MYOTHERIX, INC.
- CIK: 0001647149
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1900 Powell Street, 6th Floor, Emeryville, CA, 94608
- Phone: 857-222-4653
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Mark P de Souza | Director | Emeryville, CA |
| Babar P Ghias | Director | Emeryville, CA |
| Michael P Kelly | Director | Pleasanton, CA |
| John P Kincaid | Director | Emeryville, CA |
| Jak P Knowles | Director | Emeryville, CA |
| Mark P de Souza | Executive Officer | Emeryville, CA |
| Michael P Kelly | Executive Officer | Pleasanton, CA |
| John P Kincaid | Executive Officer | Emeryville, CA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Michael Kelly | Director | NEW YORK, NY |
| Michael Kelly | Executive Officer | NEW YORK, NY |
| Jak Knowles | Director | Berkeley, CA |
| John Kincaid | Director | Union City, CA |
| John Kincaid | Executive Officer | Union City, CA |
Other filings by this issuer (2)
More